CN Stock MarketDetailed Quotes

300630 Hainan Poly Pharm

Watchlist
  • 9.01
  • -0.17-1.85%
Market Closed Dec 13 15:00 CST
4.07BMarket Cap-38.34P/E (TTM)

Hainan Poly Pharm Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

All
YOY yoy
Hide blank lines yoy
(Q9)Sep 30, 2024
(Q6)Jun 30, 2024
(Q3)Mar 31, 2024
(FY)Dec 31, 2023
(Q9)Sep 30, 2023
(Q6)Jun 30, 2023
(Q3)Mar 31, 2023
(FY)Dec 31, 2022
(Q9)Sep 30, 2022
(Q6)Jun 30, 2022
Total operating revenue
0.34%625.24M
-6.99%437.46M
42.69%306.33M
-19.43%1.3B
-54.54%623.14M
-40.88%470.35M
-41.65%214.67M
24.67%1.62B
20.59%1.37B
27.69%795.6M
Operating revenue
0.34%625.24M
-6.99%437.46M
42.69%306.33M
-19.43%1.3B
-54.54%623.14M
-40.88%470.35M
-41.65%214.67M
24.67%1.62B
20.59%1.37B
27.69%795.6M
Other operating revenue
----
----
----
223.32%48.21M
----
104.10%10.85M
----
1.41%14.91M
----
437.41%5.32M
Total operating cost
5.95%814.53M
13.12%549.22M
11.02%222.05M
-2.14%1.3B
-14.68%768.78M
-6.40%485.52M
-5.68%200.01M
39.13%1.33B
22.96%901.02M
32.43%518.71M
Operating cost
5.76%251.19M
1.28%155.22M
21.35%74.21M
-37.67%351.51M
-25.83%237.51M
-21.39%153.26M
-18.91%61.15M
61.82%563.98M
24.68%320.23M
40.31%194.96M
Operating tax surcharges
20.63%6.93M
-6.68%4.28M
-67.65%768.35K
43.29%17.49M
44.18%5.75M
63.85%4.58M
42.55%2.37M
-30.87%12.21M
-40.63%3.99M
-33.37%2.8M
Operating expense
47.10%264.31M
40.45%178.82M
-6.52%47.8M
31.17%459.96M
5.01%179.68M
25.20%127.32M
7.20%51.14M
50.39%350.65M
7.12%171.1M
19.50%101.69M
Administration expense
19.75%105.95M
36.04%72.77M
135.21%35.43M
46.03%156.72M
5.65%88.47M
9.88%53.49M
18.44%15.06M
30.94%107.32M
6.91%83.74M
16.89%48.68M
Financial expense
55.17%42.73M
79.06%27.11M
3.97%9.11M
48.13%47.32M
-56.79%27.54M
-60.29%15.14M
-51.06%8.76M
-28.56%31.94M
135.17%63.73M
212.32%38.13M
-Interest expense (Financial expense)
29.24%42.83M
53.35%32.02M
----
35.39%54.36M
-51.18%33.14M
-50.94%20.88M
----
-27.92%40.15M
682.46%67.89M
173.65%42.57M
-Interest Income (Financial expense)
9.42%-3.76M
-37.30%-4.92M
---1.73M
4.04%-4.73M
-20.32%-4.16M
4.27%-3.58M
----
58.43%-4.93M
55.29%-3.45M
23.96%-3.74M
Research and development
-37.60%143.43M
-15.71%111.02M
-11.02%54.74M
1.76%267.67M
-11.00%229.84M
-0.56%131.72M
8.58%61.52M
14.70%263.04M
26.52%258.24M
20.85%132.46M
Credit Impairment Loss
109.53%23.13M
-53.00%7.94M
-89.50%1.15M
-10.23%-28.1M
150.59%11.04M
1,504.87%16.89M
978.72%10.99M
-170.84%-25.49M
-39.04%-21.83M
117.72%1.05M
Asset Impairment Loss
-401.77%-3.02M
-317.78%-2.51M
----
---15.75M
---601.62K
---601.62K
----
----
----
----
Other net revenue
-11.74%64.34M
-51.96%27.03M
-81.55%4.15M
4,723.98%44.08M
6,503.21%72.9M
152.82%56.27M
89.13%22.52M
-292.44%-953.35K
113.33%1.1M
2,811.71%22.26M
Fair value change income
----
----
----
----
----
----
----
---94.44K
----
----
Invest income
67.55%7.61M
-19.12%2.54M
--0
414.06%4.4M
154.58%4.54M
75.76%3.13M
1,646.10%2.46M
60.47%-1.4M
--1.78M
--1.78M
Other revenue
-36.78%36.61M
-48.25%19.07M
-66.92%3M
220.89%83.53M
173.87%57.92M
89.75%36.85M
-30.31%9.07M
93.77%26.03M
185.19%21.15M
190.62%19.42M
Operating profit
-71.78%-124.95M
-306.10%-84.73M
137.79%88.43M
-83.43%47.89M
-115.45%-72.74M
-86.26%41.11M
-77.83%37.19M
-15.94%289.04M
19.02%470.77M
28.88%299.15M
Add:Non operating Income
121.92%311.96K
-10.21%91.47K
191.40%56.53K
16,829.31%29.38M
35.74%140.58K
233.71%101.87K
7.98%19.4K
-70.95%173.57K
-5.66%103.56K
-47.72%30.53K
Less:Non operating expense
6,540.66%12.81M
23,861.56%3.58M
35,041.68%28.83K
222.92%2.45M
18,415.62%192.86K
14,217.90%14.95K
--82.03
-34.06%758.94K
-99.91%1.04K
-99.20%104.4
Total profit
-88.82%-137.45M
-314.14%-88.22M
137.74%88.46M
-74.06%74.82M
-115.46%-72.79M
-86.23%41.2M
-77.83%37.21M
-15.98%288.45M
19.36%470.88M
28.87%299.18M
Less:Income tax cost
76.47%-39.18M
43.68%-31.4M
174.57%21.77M
-68.50%-11.1M
-1,180.20%-166.48M
-581.89%-55.76M
-585.64%-29.19M
-116.86%-6.59M
255.27%15.41M
64.56%11.57M
Net profit
-204.89%-98.27M
-158.60%-56.81M
0.44%66.69M
-70.88%85.92M
-79.43%93.69M
-66.29%96.95M
-58.96%66.4M
-3.02%295.04M
16.73%455.46M
27.75%287.61M
Net profit from continuing operation
-204.89%-98.27M
-158.60%-56.81M
0.44%66.69M
-70.88%85.92M
-79.43%93.69M
-66.29%96.95M
-58.96%66.4M
-3.02%295.04M
16.73%455.46M
27.75%287.61M
Net profit of parent company owners
-204.89%-98.27M
-158.60%-56.81M
0.44%66.69M
-70.88%85.92M
-79.43%93.69M
-66.29%96.95M
-58.96%66.4M
-3.02%295.04M
16.73%455.46M
27.75%287.61M
Earning per share
Basic earning per share
-204.76%-0.22
-186.67%-0.13
0.00%0.15
-70.59%0.2
-79.81%0.21
-77.27%0.15
-59.46%0.15
-2.86%0.68
16.85%1.04
26.92%0.66
Diluted earning per share
-205.00%-0.21
-185.71%-0.12
0.00%0.14
-69.84%0.19
-80.77%0.2
-77.78%0.14
-62.16%0.14
-10.00%0.63
16.85%1.04
26.00%0.63
Other composite income
Total composite income
-204.89%-98.27M
-158.60%-56.81M
0.44%66.69M
-70.88%85.92M
-79.43%93.69M
-66.29%96.95M
-58.96%66.4M
-3.02%295.04M
16.73%455.46M
27.75%287.61M
Total composite income of parent company owners
-204.89%-98.27M
-158.60%-56.81M
0.44%66.69M
-70.88%85.92M
-79.43%93.69M
-66.29%96.95M
-58.96%66.4M
-3.02%295.04M
16.73%455.46M
27.75%287.61M
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
Audit Opinions
--
--
--
Reservations with explanatory notes
--
--
--
Unqualified opinion
--
--
Auditor
--
--
--
Tianjian Certified Public Accountants (Special General Partnership)
--
--
--
Tianjian Certified Public Accountants (Special General Partnership)
--
--
(Q9)Sep 30, 2024(Q6)Jun 30, 2024(Q3)Mar 31, 2024(FY)Dec 31, 2023(Q9)Sep 30, 2023(Q6)Jun 30, 2023(Q3)Mar 31, 2023(FY)Dec 31, 2022(Q9)Sep 30, 2022(Q6)Jun 30, 2022
Total operating revenue 0.34%625.24M-6.99%437.46M42.69%306.33M-19.43%1.3B-54.54%623.14M-40.88%470.35M-41.65%214.67M24.67%1.62B20.59%1.37B27.69%795.6M
Operating revenue 0.34%625.24M-6.99%437.46M42.69%306.33M-19.43%1.3B-54.54%623.14M-40.88%470.35M-41.65%214.67M24.67%1.62B20.59%1.37B27.69%795.6M
Other operating revenue ------------223.32%48.21M----104.10%10.85M----1.41%14.91M----437.41%5.32M
Total operating cost 5.95%814.53M13.12%549.22M11.02%222.05M-2.14%1.3B-14.68%768.78M-6.40%485.52M-5.68%200.01M39.13%1.33B22.96%901.02M32.43%518.71M
Operating cost 5.76%251.19M1.28%155.22M21.35%74.21M-37.67%351.51M-25.83%237.51M-21.39%153.26M-18.91%61.15M61.82%563.98M24.68%320.23M40.31%194.96M
Operating tax surcharges 20.63%6.93M-6.68%4.28M-67.65%768.35K43.29%17.49M44.18%5.75M63.85%4.58M42.55%2.37M-30.87%12.21M-40.63%3.99M-33.37%2.8M
Operating expense 47.10%264.31M40.45%178.82M-6.52%47.8M31.17%459.96M5.01%179.68M25.20%127.32M7.20%51.14M50.39%350.65M7.12%171.1M19.50%101.69M
Administration expense 19.75%105.95M36.04%72.77M135.21%35.43M46.03%156.72M5.65%88.47M9.88%53.49M18.44%15.06M30.94%107.32M6.91%83.74M16.89%48.68M
Financial expense 55.17%42.73M79.06%27.11M3.97%9.11M48.13%47.32M-56.79%27.54M-60.29%15.14M-51.06%8.76M-28.56%31.94M135.17%63.73M212.32%38.13M
-Interest expense (Financial expense) 29.24%42.83M53.35%32.02M----35.39%54.36M-51.18%33.14M-50.94%20.88M-----27.92%40.15M682.46%67.89M173.65%42.57M
-Interest Income (Financial expense) 9.42%-3.76M-37.30%-4.92M---1.73M4.04%-4.73M-20.32%-4.16M4.27%-3.58M----58.43%-4.93M55.29%-3.45M23.96%-3.74M
Research and development -37.60%143.43M-15.71%111.02M-11.02%54.74M1.76%267.67M-11.00%229.84M-0.56%131.72M8.58%61.52M14.70%263.04M26.52%258.24M20.85%132.46M
Credit Impairment Loss 109.53%23.13M-53.00%7.94M-89.50%1.15M-10.23%-28.1M150.59%11.04M1,504.87%16.89M978.72%10.99M-170.84%-25.49M-39.04%-21.83M117.72%1.05M
Asset Impairment Loss -401.77%-3.02M-317.78%-2.51M-------15.75M---601.62K---601.62K----------------
Other net revenue -11.74%64.34M-51.96%27.03M-81.55%4.15M4,723.98%44.08M6,503.21%72.9M152.82%56.27M89.13%22.52M-292.44%-953.35K113.33%1.1M2,811.71%22.26M
Fair value change income -------------------------------94.44K--------
Invest income 67.55%7.61M-19.12%2.54M--0414.06%4.4M154.58%4.54M75.76%3.13M1,646.10%2.46M60.47%-1.4M--1.78M--1.78M
Other revenue -36.78%36.61M-48.25%19.07M-66.92%3M220.89%83.53M173.87%57.92M89.75%36.85M-30.31%9.07M93.77%26.03M185.19%21.15M190.62%19.42M
Operating profit -71.78%-124.95M-306.10%-84.73M137.79%88.43M-83.43%47.89M-115.45%-72.74M-86.26%41.11M-77.83%37.19M-15.94%289.04M19.02%470.77M28.88%299.15M
Add:Non operating Income 121.92%311.96K-10.21%91.47K191.40%56.53K16,829.31%29.38M35.74%140.58K233.71%101.87K7.98%19.4K-70.95%173.57K-5.66%103.56K-47.72%30.53K
Less:Non operating expense 6,540.66%12.81M23,861.56%3.58M35,041.68%28.83K222.92%2.45M18,415.62%192.86K14,217.90%14.95K--82.03-34.06%758.94K-99.91%1.04K-99.20%104.4
Total profit -88.82%-137.45M-314.14%-88.22M137.74%88.46M-74.06%74.82M-115.46%-72.79M-86.23%41.2M-77.83%37.21M-15.98%288.45M19.36%470.88M28.87%299.18M
Less:Income tax cost 76.47%-39.18M43.68%-31.4M174.57%21.77M-68.50%-11.1M-1,180.20%-166.48M-581.89%-55.76M-585.64%-29.19M-116.86%-6.59M255.27%15.41M64.56%11.57M
Net profit -204.89%-98.27M-158.60%-56.81M0.44%66.69M-70.88%85.92M-79.43%93.69M-66.29%96.95M-58.96%66.4M-3.02%295.04M16.73%455.46M27.75%287.61M
Net profit from continuing operation -204.89%-98.27M-158.60%-56.81M0.44%66.69M-70.88%85.92M-79.43%93.69M-66.29%96.95M-58.96%66.4M-3.02%295.04M16.73%455.46M27.75%287.61M
Net profit of parent company owners -204.89%-98.27M-158.60%-56.81M0.44%66.69M-70.88%85.92M-79.43%93.69M-66.29%96.95M-58.96%66.4M-3.02%295.04M16.73%455.46M27.75%287.61M
Earning per share
Basic earning per share -204.76%-0.22-186.67%-0.130.00%0.15-70.59%0.2-79.81%0.21-77.27%0.15-59.46%0.15-2.86%0.6816.85%1.0426.92%0.66
Diluted earning per share -205.00%-0.21-185.71%-0.120.00%0.14-69.84%0.19-80.77%0.2-77.78%0.14-62.16%0.14-10.00%0.6316.85%1.0426.00%0.63
Other composite income
Total composite income -204.89%-98.27M-158.60%-56.81M0.44%66.69M-70.88%85.92M-79.43%93.69M-66.29%96.95M-58.96%66.4M-3.02%295.04M16.73%455.46M27.75%287.61M
Total composite income of parent company owners -204.89%-98.27M-158.60%-56.81M0.44%66.69M-70.88%85.92M-79.43%93.69M-66.29%96.95M-58.96%66.4M-3.02%295.04M16.73%455.46M27.75%287.61M
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)
Audit Opinions ------Reservations with explanatory notes------Unqualified opinion----
Auditor ------Tianjian Certified Public Accountants (Special General Partnership)------Tianjian Certified Public Accountants (Special General Partnership)----

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Heat List
CN
Overall
Symbol
Price
% Chg

No Data

Investment Theme Superfungus
Superfungus
Intraday-1.74%